Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Cambridge Tech Podcast

AnthroTek - from Hollywood to MedTech and Robotics

24 Jun 2025

Description

This week’s episode features a fascinating interview with Nazmus Tareque and Raoul Peltier, co-founders of AnthroTek, a startup that is pushing the boundaries of material science in medical and robotics applications.Nazmus and Raoul come from very different worlds - law and VC on one side, drug delivery and materials science on the other - but together they’re building hyper-realistic silicone solutions for real world impact.A few standout moments from the conversation:🧠 “We started with this idea of what the market might need, and very early on, we realised the demand is not for hyperrealism, but for functionality.” – Raoul🌍 “We want to stay a humane company that finds solutions that help people and the planet.” – NazmusKey Takeaways from the Interview:• The duo emphasised the importance of market discovery, stating, “We literally started with a lot of ideas and we didn’t know which one was going to work.” This approach has allowed them to refine their focus on medical applications, which currently account for 80% of their revenue.• Both founders are passionate about sustainability, aiming to develop biodegradable alternatives to traditional silicone. “We are really interested in using our material science knowledge to explore can we find within five years an alternative to silicone that is actually biodegradable,” Nazmus shared.• The Cambridge tech scene has played a pivotal role in their success and they highlighted the importance of networking and collaboration.Produced by Cambridge TV Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.